EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 172 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $123 | -10.2% | 4,350 | -7.5% | 0.00% | – |
| Q4 2022 | $137 | -99.9% | 4,703 | +8.6% | 0.00% | – |
| Q3 2022 | $114,000 | -40.6% | 4,330 | 0.0% | 0.00% | – |
| Q2 2022 | $192,000 | +62.7% | 4,330 | +80.1% | 0.00% | – |
| Q1 2022 | $118,000 | -3.3% | 2,404 | -0.0% | 0.00% | – |
| Q4 2021 | $122,000 | +1.7% | 2,405 | +11.5% | 0.00% | – |
| Q3 2021 | $120,000 | +62.2% | 2,157 | +34.0% | 0.00% | – |
| Q4 2020 | $74,000 | +1380.0% | 1,610 | +1208.9% | 0.00% | – |
| Q3 2020 | $5,000 | -91.8% | 123 | -90.4% | 0.00% | – |
| Q2 2020 | $61,000 | -99.7% | 1,277 | -99.6% | 0.00% | -100.0% |
| Q2 2018 | $24,388,000 | +42.7% | 322,340 | -0.6% | 0.04% | +44.8% |
| Q1 2018 | $17,085,000 | -13.0% | 324,257 | -11.8% | 0.03% | -14.7% |
| Q4 2017 | $19,631,000 | -6.4% | 367,497 | +4.5% | 0.03% | -10.5% |
| Q3 2017 | $20,973,000 | -4.5% | 351,673 | +26.4% | 0.04% | -7.3% |
| Q2 2017 | $21,953,000 | +990.6% | 278,282 | +1046.4% | 0.04% | +925.0% |
| Q1 2017 | $2,013,000 | -24.0% | 24,275 | -27.3% | 0.00% | -20.0% |
| Q4 2016 | $2,649,000 | +13.3% | 33,400 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $2,338,000 | +80.5% | 33,400 | 0.0% | 0.01% | +66.7% |
| Q2 2016 | $1,295,000 | – | 33,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |